Ergebnis der Suchanfrage nach Rhein
Newsrooms
Dienststellen
Inhalte
- Kategorie:
- Sprache:
- Medien:
- Zeitraum:
- Zeitraum:Gesamt
- 4mehr
Lack of Privacy Transparency in the Smart Home Sector: ONEKEY analyses IoT Devices together with German Universities
Lack of Privacy Transparency in the Smart Home Sector: ONEKEY analyses IoT Devices together with German Universities The UnboxingIoTPrivacy research project focuses on systematically inspecting the privacy characteristics of IoT devices to educate consumers. Duesseldorf, February 23rd, 2024 - Smart devices that are ...
mehrLIQID lowers entry barrier for Private Equity to 10,000 euros
mehrBIRKENSTOCK APPOINTS NEW MANAGING DIRECTOR FOR GREATER CHINA: TIFFANY WU TO LEAD AND TO ACCELERATE THE COMPANY’S EXPANSION IN THE GROWTH REGION WITH THE LARGEST UNTAPPED WHITE SPACE POTENTIAL
mehr- 2
Democratisation of Private Equity Gains Pace: LIQID Closes EUR200 Million Fund for Affluent Investors
mehr German dog food is prepared differently - Now also available in UK
mehr
- 11
"Germany-does-not-fly" / The campaign of the year 2020 against domestic flights has started at Frankfurt Int. Airport / "Deutschland-fliegt-nicht" die Kampagne des Jahres 2020 gegen Inlandsflüge startete im Frankfurter Flughafen
mehr "Deutschland fliegt nicht" - Germany Grounded / Nationwide campaign against domestic flights begins on Nov. 11th, 2019 at Frankfurt Int. Airport
Hochheim (ots) - "From Feb. 10th until Feb. 16th 2020 we wish that as many people as possible give up their private or business domestic flights and stay grounded", so the official statement from "Gegenwind 2011". The nationwide campaign "Germany doesn't fly" is much more than a normal protest. Simply not flying is ...
mehrLogistics and Real Estate 2018 - Beyond the Hype. The "Bread and Butter Business" of Logistics
Berlin/Hamburg/Munich (ots) - Logistics Specialists' "Bread and Butter" Business creates Strong Growth - Germany's logistics property market continues to grow - but will not repeat 2017 record results - First half-year investment volume 2018 only 66 percent of previous-year period - Foreign investors create 75 percent of total revenue - Regional analysis: Rhein-Ruhr ...
mehrtrivago reports only 20 percent hotel availability from 1 to 2 July 2017 / Plan your Grand Départ visit now - hotels in high demand
Duesseldorf (ots) - For the cycling event Grand Départ Düsseldorf 2017, the start of the Tour de France, visitors will be coming to the state capital of North Rhine-Westphalia from far and wide on the first weekend in July. An international sporting event, a "public festival" along the route and a friendly ...
mehrUnique Master's programme in Social Protection starts this year
Sankt Augustin (ots) - The Bonn-Rhein-Sieg University of Applied Sciences expands its portfolio for international professionals by introducing the new study programme "Analysis and Design of Social Protection Systems" (MA) "The goal is to enable students from various countries to analyse social protection systems and design them in light of the national needs and capacities," claimed Professor Dr Esther Schüring, ...
mehrDeutsche Energie-Agentur GmbH (dena)
Planning of electricity and gas networks at European level / EU project: Integration of large shares of renewable energy requires a trans-national strategy
Brussels/Berlin (ots) - The EU countries should develop a joint strategy for the development of European energy infrastructures. According to the participants in the SUSPLAN (PLANning for SUStainability) project, this is a basic requirement for further expanding renewable energy and climate protection beyond current ...
mehr
EANS-News: WACKER Sells its Tire-Release-Agent Business to Rhein Chemie
company: Wacker Chemie AG Hanns-Seidel-Platz 4 D-81737 München phone: +49 (0) 89 6279 01 FAX: +49 (0) 89 6279 1770 mail: info@wacker.com WWW: http://www.wacker.com sector: Chemicals ISIN: DE000WCH8881 indexes: Midcap Market Index, MDAX, CDAX, Classic All Share, HDAX, Prime All Share stockmarkets: regulated dealing/prime standard: Frankfurt language: English ...
mehrHead-to-Head Trial Demonstrates Viramune(R)'s Similar Efficacy and Superior Effect on Lipid Profile Compared to atazanavir/ritonavir
Cape Town, South Africa (ots/PRNewswire) - - For Medical Media Outside the US Only Results from the ARTEN* trial presented at the 5th International AIDS Society (IAS) conference in Cape Town, South Africa demonstrated non-inferiority regarding efficacy between Viramune(R) (nevirapine) and ritonavir boosted ...
mehrEuropean Commission Approves Statement on Lipid Improvement for VIRAMUNE(R) Label
Ingelheim, Germany (ots/PRNewswire) - - For Medical Media Outside the US only Boehringer Ingelheim announced today that the European Commission has approved an update of the Summary of Product Characteristics (SmPC) for VIRAMUNE(R) (nevirapine) in the treatment of patients with HIV. The decision followed a positive recommendation by the Committee for Medical Products ...
mehrNew Powerful Antihypertensive MicardisPlus(R) 80/25 (80mg telmisartan/25mg hydrochlorothiazide) Approved by EU Commission
Ingelheim, Germany (ots/PRNewswire) - - For Medical Media, Outside the US Only Boehringer Ingelheim today announced that the European Commission has granted marketing authorisation of the new powerful strength of their fixed dose combination antihypertensive drug MicardisPlus(R) 80/25 in all 27 EU member states. It ...
mehrEfficacy of Boehringer Ingelheim's Pramipexole (Mirapexin(R)/Sifrol(R) Also Demonstrated in Patients With Daytime RLS Symptoms
Ingelheim Am Rhein, Germany (ots/PRNewswire) - - Studies Reinforce the Benefits of Pramipexole From Daytime Symptom Control, Including Afternoon and Early Evening Onset - For Healthcare Media Outside the U.S.A. New data demonstrate that pramipexole (Mirapexin(R)/Sifrol(R)) is also efficacious and ...
mehrLong-Term Data Show Aptivus(R) (tipranavir) Continues to Outperform Group of Protease Inhibitors in RESIST Trials
Glasgow, Scotland, November 15 (ots/PRNewswire) - - New Sub-analyses Provide Insight into Treatment Benefits New data from the combined RESIST studies (RESIST-1 and RESIST-2) show that Aptivus(R) (tipranavir), used with ritonavir (tipranavir/r) as part of combination antiretroviral therapy, continued to ...
mehr